Literature DB >> 18260124

Challenges in IBD research: Assessing progress and rethinking the research agenda.

William F Stenson1, Scott B Snapper.   

Abstract

Mesh：

Year:  2008        PMID： 18260124     DOI： 10.1002/ibd.20371

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN： 1078-0998            Impact factor:   5.325


× No keyword cloud information.
  4 in total

1.  Molecular profiling of mucosal tissue associated microbiota in patients manifesting acute exacerbations and remission stage of ulcerative colitis.

Authors:  Sandeep A Walujkar; Shreyas V Kumbhare; Nachiket P Marathe; Dhrati V Patangia; Parimal S Lawate; Renu S Bharadwaj; Yogesh S Shouche
Journal:  World J Microbiol Biotechnol       Date:  2018-05-23       Impact factor: 3.312

2.  Fluctuations in butyrate-producing bacteria in ulcerative colitis patients of North India.

Authors:  Reena Kumari; Vineet Ahuja; Jaishree Paul
Journal:  World J Gastroenterol       Date:  2013-06-14       Impact factor: 5.742

3.  African-American inflammatory bowel disease in a Southern U.S. health center.

Authors:  Hemanth Veluswamy; Kunal Suryawala; Ankur Sheth; Shannon Wells; Erik Salvatierra; Walter Cromer; Ganta V Chaitanya; Annette Painter; Mihir Patel; Kenneth Manas; Ellenmarie Zwank; Moheb Boktor; Kondal Baig; Balaji Datti; Michael J Mathis; Alireza Minagar; Paul A Jordan; Jonathan S Alexander
Journal:  BMC Gastroenterol       Date:  2010-09-09       Impact factor: 3.067

4.  Challenges in IBD research: update on progress and prioritization of the CCFA's research agenda.

Authors:  Lee A Denson; Millie D Long; Dermot P B McGovern; Subra Kugathasan; Gary D Wu; Vincent B Young; Theresa T Pizarro; Edwin F de Zoeten; Thaddeus S Stappenbeck; Scott E Plevy; Clara Abraham; Asma Nusrat; Christian Jobin; Declan F McCole; Corey A Siegel; Peter D R Higgins; Hans H Herfarth; Jeffrey Hyams; William J Sandborn; Edward V Loftus; Michael D Kappelman; James D Lewis; Charles A Parkos; R Balfour Sartor
Journal:  Inflamm Bowel Dis       Date:  2013 Mar-Apr       Impact factor: 5.325
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.